Abstract library

5 results for "Nakano".
#1392 How Long Should We Look Up for Recurrence After Resection of Pancreatic Neuroendocrine Tumors?
Introduction: There remains several unsolved issues to be settled about the management of pancreatic neuroendocrine tumors (PNETs) after resection. One of these problems are the follow up period after a complete resection of the tumor.
Conference: 13th Annual ENETS conference (2016)
Category: Surgical treatment
Presenting Author: MD Asahi Sato
Authors: Sato A, Masui T, Nakano K, Kawaguchi Y, ...
#1428 Factors Affecting Recurrences of the Non-functioning Pancreatic NET After Resection
Introduction: In 2010, WHO classification has been modified. However, the usefulness of the criteria for surgeons has not been elucidated, because the criteria is defined by cell growth represented by Ki67 for overall survival and may not represent invasiveness of the tumor.
Conference: 13th Annual ENETS conference (2016)
Category: Surgical treatment
Presenting Author: M.D., Ph.D. Toshihiko Masui
Authors: Masui T, Sato A, Nakano K, Nakamoto Y, ...
Keywords: WHO2010, invasiveness
#1464 A Case of Multiple Pancreatic Insulinoma Laparoscopically Resected through Precise Spatial Diagnosis by SACI Test
Introduction: Case: A 58-year-old man representing cold sweat, palpitation and nausea was admitted to our hospital and was pointed out parathyroid, pancreatic and superior mediastinal masses with CT.
Conference: 13th Annual ENETS conference (2016)
Category: Clinical cases/reports
Presenting Author: Kenzo Nakano
Authors: Nakano K, Masui T, Sato A, Ito T, ...
#1692 A Case Report of NET G1 of the Gallbladder
Introduction: The SEER database has shown that gallbladder NET is 0.5% of all NET cases, and G1 cases are limited to 2% in the rare gallbladder NET cases.
Conference: 14th Annual ENETS conference (2017)
Category: Clinical cases/reports
Presenting Author: Kenzo Nakano
Authors: Nakano K, Masui T, Uchida Y, Sato A, ...
Keywords: NET G1, gallbladder
#2203 A Case of Rectal Abscess Emerged Immediately after Starting Chemotherapy with Everolimus and Required Surgical Drainage
Introduction: <Introduction>Everolimus is widely used for unresectable panNET. For its efficacy as an immunosuppressant, infectious adverse events are well-known.
Conference: 15th Annual ENETS conference (2018)
Category: Case reports
Presenting Author: Kenzo Nakano
Authors: Nakano K, Masui T, Yogo A, Uchida Y, ...